Loxo Oncology Profile

USD 0.31  0.35%
83.45Last Month High 94.01 
86.0Trading Day  High 90.35 

Acquisition by Timothy Mayleben of 7812 shares of Loxo Oncology subject to Rule 16b-3

Loxo Oncology Inc insider trading alert for grant of director stock option (right to buy) by Timothy Mayleben, the corporate stakeholder, on October 1, 2017. This event was filed by Loxo Oncology Inc with SEC on 2016-06-13. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Loxo Oncology Summary

Loxo Oncology Inc (LOXO) is traded on NASDAQ General Markets in USA. It is located in CONNECTICUT, U.S.A and employs 25 people. Loxo Oncology is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 2.63 B. Loxo Oncology Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 29.85 M outstanding shares of which 3.51 M shares are now shorted by private and institutional investors with about 12.9 trading days to cover. Loxo Oncology currently holds about 467.58 M in cash with (80.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.66.
Check Loxo Oncology Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Loxo Oncology Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Loxo Oncology Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 30% 
Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined cancers primarily in the United States. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameLoxo Oncology Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business AddressLoxo Oncology, Inc.Stamford, CT
ExchangeNASDAQ General Markets
CIK Number01581720.0
Contact Number203 653 3880
CurrencyUSD - US Dollar

Current Sentiment - LOXO

Loxo Oncology Inc Investor Sentiment
Most of Macroaxis users are now bullish on Loxo Oncology Inc. What is your trading attitude regarding investing in Loxo Oncology Inc? Are you bullish or bearish?
98% Bullish
2% Bearish
LoxoSkip  Hide


Loxo Oncology Analyst Recommendations
Target PriceAdvice# of Analysts
50.33Strong Buy3Odds
Loxo Oncology Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Loxo Oncology Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Loxo Oncology Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.86March 21, 2017
Loxo Oncology Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate